A tagged excavation element, including an excavation element body and a tagging device securable to the excavation element body. The tagged excavation element is characterized in that the tagging device includes a man-made radioactive source. Typically, but not exclusively, the excavation element body comprises a shroud or tooth of an excavation bucket of a ground excavation tool (GET). A method is provided for manufacturing the tagged excavation element, and for detecting the tagged excavation element.

Described herein are bioreductively-activated compounds, their prodrugs, radiopharmaceuticals, the compositions, and their application in multimodal theranostic management of hypoxia diseases including cancer.

A shielding assembly may be used in a nuclear medicine infusion system that generates and infuse radioactive liquid into a patient undergoing a diagnostic imaging procedure. In some examples, the shielding assembly has multiple compartments each formed of a shielding material providing a barrier to radioactive radiation. For example, the shielding assembly may have a first compartment configured to receive a radioisotope generator that generates a radioactive eluate via elution, a second compartment configured to receive a beta detector, and a third compartment configured to receive a gamma detector. In some examples, the compartments are arranged to minimize background radiation emitted by the radioisotope generator and detected by the gamma detector to enhance the quality of the measurements made by the gamma detector.

A shielding assembly may be used in a nuclear medicine infusion system that generates and infuse radioactive liquid into a patient undergoing a diagnostic imaging procedure. In some examples, the shielding assembly has multiple compartments each formed of a shielding material providing a barrier to radioactive radiation. For example, the shielding assembly may have a first compartment configured to receive a radioisotope generator that generates a radioactive eluate via elution, a second compartment configured to receive a beta detector, and a third compartment configured to receive a gamma detector. In some examples, the compartments are arranged to minimize background radiation emitted by the radioisotope generator and detected by the gamma detector to enhance the quality of the measurements made by the gamma detector.

Surrogate materials are in the form of solid particles that include surrogate isotopes, namely, short-lived isotopes selected and formed to serve as surrogates for the radioactive materials of a nuclear fallout without including isotopes that are, or that decay to, biologically or environmentally deleterious and persistent isotopes. The surrogate material may be formed using high-purity reactant material and irradiation and separation techniques that enable tailoring of the isotopes and ratios thereof included in the surrogate material, and the surrogate material may be dispersed, e.g., in a training environment, in solid form.

The present invention discloses a DBN based separation method of a mixture of dual-tracer single-acquisition PET signals labelled with the same isotope. It predicts the two separate PET signals by establishing a complex mapping relationship between the dynamic mixed concentration distribution of the same isotope-labeled dual-tracer pairs and the two single radiotracer concentration images. Based on the compartment models and the Monte Carlo simulation, the present invention selects three sets of the same radionuclide-labeled tracer pairs as the objects and simulates the entire PET process from injection to scanning to generate enough training sets and testing sets. When inputting the testing sets into the constructed universal deep belief network trained by the training sets, the prediction results show that the two individual PET signals can been reconstructed well, which verifies the effectiveness of using the deep belief network to separate the dual-tracer PET signals labelled with the same isotope.

The present invention discloses a DBN based separation method of a mixture of dual-tracer single-acquisition PET signals labelled with the same isotope. It predicts the two separate PET signals by establishing a complex mapping relationship between the dynamic mixed concentration distribution of the same isotope-labeled dual-tracer pairs and the two single radiotracer concentration images. Based on the compartment models and the Monte Carlo simulation, the present invention selects three sets of the same radionuclide-labeled tracer pairs as the objects and simulates the entire PET process from injection to scanning to generate enough training sets and testing sets. When inputting the testing sets into the constructed universal deep belief network trained by the training sets, the prediction results show that the two individual PET signals can been reconstructed well, which verifies the effectiveness of using the deep belief network to separate the dual-tracer PET signals labelled with the same isotope.

A nuclear medicine infusion system (10) may be used to generate and infuse radioactive liquid into a patient undergoing a diagnostic imaging procedure. In some examples, the infusion system includes a frame (30) that carries a radioisotope generator (52) that generates radioactive eluate via elution. The frame may also carry a beta detector (58) and a gamma detector (60). The beta detector can be positioned to measure beta emissions emitted from the radioactive eluate supplied by the generator. The gamma detector can be positioned to measure gamma emissions emitted from a portion of the radioactive eluate to evaluate a safety of the radioactive eluate delivered by the infusion system.

A nuclear medicine infusion system (10) may be used to generate and infuse radioactive liquid into a patient undergoing a diagnostic imaging procedure. In some examples, the infusion system includes a frame (30) that carries a radioisotope generator (52) that generates radioactive eluate via elution. The frame may also carry a beta detector (58) and a gamma detector (60). The beta detector can be positioned to measure beta emissions emitted from the radioactive eluate supplied by the generator. The gamma detector can be positioned to measure gamma emissions emitted from a portion of the radioactive eluate to evaluate a safety of the radioactive eluate delivered by the infusion system.

An infusion system may include a strontium-rubidium radioisotope generator that generates a radioactive eluate via elution, a beta detector, a gamma detector, and a controller. The beta detector and the gamma detector may be positioned to measure beta emissions and gamma emissions, respectively, emitted from the radioactive eluate. In some examples, the controller is configured to determine an activity of rubidium in the radioactive eluate based on the beta emissions measured by the beta detector and determine an activity of strontium in the radioactive eluate based on the gamma emissions measured by the gamma detector.